{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_001126113.2:c.158C>A",
          "cDNA Change": {
            "transcript": "NM_001126113.2",
            "ref": "C",
            "alt": "A",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T mutation in α-synuclein"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005291"
  },
  "Experiment Method": [
    {
      "Assay Method": "Cell culture and functional analysis",
      "Material used": {
        "Material Source": "Primary cortical neurons",
        "Material Name": "Overexpressing mutant A53T α-synuclein",
        "Description": "Primary cortical neurons were used to study the effects of A53T α-synuclein overexpression on mitochondrial dysfunction and autophagy."
      },
      "Readout type": "Quantitative and qualitative",
      "Readout description": [
        {
          "Variant": "NM_001126113.2:c.158C>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Enhanced mitochondrial destruction and bioenergetic deficit",
          "Result Description": "Overexpression of A53T α-synuclein led to increased mitochondrial fragmentation, reduced ATP production, and neuronal degeneration. Silencing Parkin, overexpressing wild-type Mitofusin 2, or inhibiting autophagy reduced these effects."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly described in the literature"
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly described in the literature"
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not explicitly described in the literature"
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not explicitly described in the literature"
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal mitochondrial function and ATP production",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significant mitochondrial fragmentation and ATP reduction",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}